Company: MDCXW
Filing Date: 2025-03-07
Form Type: 253G1
Source: 0001062993-25-004966
Chunk: 198

Company: Medicus Pharma Ltd.
Filing Date: 2025-03-07
Form: 253G1
Chunk 198
---
 under the symbols "MDCX". The warrants offered hereby will not be listed on any U.S. securities exchange.

<div align='center'>137

EXPENSES OF THIS OFFERING</div>

Set forth below is an itemization of the total expenses, excluding commissions, which are expected to be incurred in connection with our sale of shares in this offering. With the exception of the filing fee payable to FINRA, all amounts are estimates.

| Itemized expenses               |     | Amount |         |
| FINRA filing fee                |     |        |   3,900 |
| Printing expenses               |     |        |  35,000 |
| Legal fees and expenses         |     |        | 500,000 |
| Accounting fees and expenses    |     |        | 100,000 |
| Miscellaneous fees and expenses |     |        | 111,100 |
| Total                           |     | $      | 750,000 |

<div align='center'>138

EXPERTS AND LEGAL MATTERS</div>

No expert or counsel named in this offering circular as having prepared or certified any part of this offering circular or having given an opinion upon the validity of the securities being registered or upon other legal matters in connection with the registration or offering of the securities was employed on a contingency basis or had, or is to receive, in connection with the offering, a substantial interest, directly or indirectly, in the Company or its subsidiaries. Nor was any such person connected with the Company or any of its subsidiaries as a promoter, managing or principal underwriters, voting trustee, director, officer or employee.

The financial statements included in this offering circular have been so included in reliance upon the report of MNP LLP, independent registered public accountants, upon the authority of said firm as experts in accounting and auditing.

The validity of the issuance of our common shares offered in this offering circular and certain other legal matters as to Canadian law will be passed upon for us by Bennett Jones LLP, Toronto, Canada. Certain legal matters governed by U.S. law including with respect to the warrants offered in this offering circular, will be passed upon for us by Paul, Weiss, Rifkind, Wharton & Garrison LLP, New York, New York. The Placement Agents are being represented by Pryor Cashman LLP, New York, New York.

<div align='center'>139

WHERE YOU CAN FIND MORE INFORMATION</div>

We have filed with the SEC an offering circular (including amendments and exhibits to the offering circular) on Form